Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam tosilate plus dezocine versus propofol plus dezocine for painless ultrasound-guided oocyte retrieval
ChiCTR2000036222Phase 4Not yet recruiting
- Sponsor
- Reproductive Hospital affiliated with Shandong University
- Start
- Oct 2020
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of remimazolam, propofol and dezocine in infertility (2 arms), sponsored by Reproductive Hospital affiliated with Shandong University. Primary endpoints: Blood pressure, Heart rate and 8 more. Planned start Oct 2020; status: not yet recruiting.
02
Drugs
remimazolampropofoldezocine
03
Conditions
infertility
Beyond the preview
Go deeper on ChiCTR2000036222.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000036222.